From a US FDA and EU MDR perspective is there any explicit regulatory prohibition on using a field-recovered, non-patient-contacting component (like internal shielding or structural elements) from a retired capital equipment medical device on a new device of the same model by the same manufacturer?
We are planning to have the appropriate testing and inspection upon receipt? Just curious is there any problem if we still call the new machine "new"? It is not even 2% of the machine and it is not crucial either just a piece of metal.
We are planning to have the appropriate testing and inspection upon receipt? Just curious is there any problem if we still call the new machine "new"? It is not even 2% of the machine and it is not crucial either just a piece of metal.